Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
863
Total Claims
$1.1M
Drug Cost
129
Beneficiaries
$8,689
Cost/Patient
Risk Score Breakdown 3/100
Score components are additive. Read full methodology
Peer Comparison vs. 8,541 Hematology-Oncology providers
-4%
Opioid rate vs peers
6.0% vs 6.3% avg
-36%
Cost per patient vs peers
$8,689 vs $14K avg
Opioid Prescribing
6.0%
Opioid Rate
52
Opioid Claims
$1,404
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 0 claims · $0
Generic: 632 claims · $122K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Lenalidomide | 15 | $266K |
| Apixaban | 104 | $69K |
| Rivaroxaban | 52 | $38K |
| Sucralfate | 11 | $2,122 |
| Letrozole | 59 | $1,523 |
| Anastrozole | 16 | $1,234 |
| Dexamethasone | 46 | $1,197 |
| Hydrocodone/Acetaminophen | 25 | $670 |
| Hydroxyurea | 21 | $597 |
| Acyclovir | 40 | $383 |
| Pantoprazole Sodium | 25 | $283 |
| Olanzapine | 13 | $190 |
| Amoxicillin/Potassium Clav | 17 | $178 |
| Folic Acid | 37 | $174 |
| Hydromorphone Hcl | 12 | $152 |
Prescribing Profile
Patient Profile
73
Avg Age
56%
Female
2.16
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About